Rekombinanter IL2RA (Daclizumab Biosimilar) Antikörper

Produktnummer ABIN5668118

Dieser Human Monoklonal Antikörper erkennt spezifisch IL2RA (Daclizumab Biosimilar) in FACS und BR. Er zeigt eine Reaktivität gegenüber Human, Cynomolgus und Rhesusaffen.

Kurzübersicht für Rekombinanter IL2RA (Daclizumab Biosimilar) Antikörper (ABIN5668118)

Target: IL2RA (Daclizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human, Cynomolgus, Rhesusaffen

Wirt: Human

Klonalität: Monoklonal

Konjugat: Dieser IL2RA (Daclizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Blocking Reagent (BR)

Produktdetails anti-IL2RA (Daclizumab Biosimilar) Antikörper

Verwendungszweck: Anti-IL-2R [Daclizumab], Human IgG1, kappa

Spezifität: Binds to p55 chain of IL2R on human T cells, Tac antigen, which is expressed on T cells activated by mitogens, soluble antigens, and alloantigens but not on resting T cells, thymocytes, B cells, monocytes, activated B cells, leukemic T cell blasts from patients with acute lymphoblastic leukemia, and long-term T cell lines.

Kreuzreaktivität: Cynomolgus, Rhesusaffen

Produktmerkmale:

Original Species of Ab: Human

Original Format of Ab: IgG1

Aufreinigung: Protein A affinity purified

Reinheit: > 98 % as determined by SDS-PAGE

Endotoxin-Niveau: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: Cultured T-cells derived from a patient with Mycosis fungoides.

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Details zu IL2RA (Daclizumab Biosimilar)

Target: IL2RA (Daclizumab Biosimilar)

Substanzklasse: Biosimilar

Hintergrund: CD25, Interleukin-2 receptor subunit alpha, IL-2 receptor subunit alpha, IL-2R subunit alpha, IL-2-RA, IL2-RA, TAC antigen, p55

UniProt: P01589